PROBLEMS OF IMPLEMENTATION OF SCREENING PROGRAMS FOR CERVICAL CANCER. THE ROLE OF ADHERENCE OF THE FEMALE POPULATION IN THE EFFICIENCY OF SCREENING FOR CERVICAL CANCER. LITERATURE REVIEW
Introduction. This review is devoted to the study of the problems of implementation of cervical cancer screening programs (CC) in the world and to determine the impact of adherence of the female population on the coverage of cervical cancer screening. To obtain significant results in reducing the incidence and mortality rates from cervical cancer, programs aimed at preventing and reducing the incidence of cervical cancer should provide for full coverage of all women of the target age, with full access to them. In the Republic of Kazakhstan (RK), within the framework of the National Program, since 2008, population-based cytological screening of cervical cancer has been used. To achieve positive indicators of the implementation of screening programs, it is necessary to participate in them at least 70% of the target population, in the Republic of Kazakhstan for CC screening, this figure is 48-50%. The results of the conducted studies show that the success of these programs directly depends on the level of coverage and commitment of the population to them.
Aim: to analyze literature data to highlight the problems of implementing CC screening programs in the world and to determine the impact of adherence of the female population on cervical cancer screening coverage.
Search strategy. The study included a search and analysis of relevant information from English and domestic sources, scientific publications in peer-reviewed journals published over the past 20 years. The search was carried out on the following queries: "CC screening programs", "Problems of implementation of the CC screening program", "Commitment of the female population to CC screening", "Coverage of the CC screening program".
Results. The results of this scoping study showed the main problems in the implementation of the screening program. As well as the relationship between the low level of adherence of the female population and the coverage of the CC screening program. Studies conducted in different countries reveal the need to optimize CC screening programs, increase coverage and increase the commitment of the female population to CC screening.
Conclusions. Cervical cancer screening is certainly a great progress towards reducing the burden of cervical cancer in the world. However, to achieve the final goal of reducing morbidity and mortality rates, an integrated approach is needed, the basis of which should be the study and increase in the commitment of the female population to cervical cancer screening.
Indira А. Zhetpisbayeva1,
Fatima D. Каssymbekova1,
Sholpan К. Sarmuldaeva2,
Natalya E. Glushkova2, https://orcid.org/0000-0003-1400-8436
1 Kazakhstan Medical University "Kazakhstan School of Public Health", Almaty, Republic of Kazakhstan;
2 Al-Farabi Kazakh National University, Almaty, Republic of Kazakhstan.
1. Бебнева Т.Н., Прилепская В.Н. Профилактика рака шейки матки: скрининг (обзор литературы) // Доктор Ру.2009. № 6. С. 11–17.
2. Бекмухамбетов Е.Ж., Балмагамбетова С.К. Современные тенденции в области скрининга рака шейки матки // Онкология и радиология Казахстана. 2017. № 2(44). С. 30-33.
3. Бестаева Н.В., Назарова Н.М., Прилепская В.Н., Трофимов Д.Ю., Бурменская О.В., Суламанидзе Л.А. Папилломавирусная инфекция: новые взгляды на диагностику и лечение (обзор литературы) // Гинекология. 2013. № 3.С. 4–6
4. Данные научно-исследовательского института онкологии и радиологии // https://onco.kz/skrining-na-rannee-vyyavlenie-raka-molochnoj-zhelezy. (accessed: 20.10.2022)
5. Серов В.Н., Твердикова М.А., Тютюнник В.Л. Папилломавирусная инфекция гениталий: основные принципы лечения // Русский медицинский журнал. 2010. № 18(19). С. 1170–1173.
6. Шалабекова М.Т., Кудайбергенова Т.А. Влияние программ популяционного скрининга на показатели рака репродуктивной системы // Вестник Алматинского государственного института усовершенствования врачей. 2018. №3. С. 67–75.
7. Шамсутдинова А.Г., Турдалиева Б.А., Рамазанова Б.А., Белтенова А.Г. Приверженность к скринингу рака молочной железы и рака шейки матки в Казахстане с позиций соблюдения этических принципов // Сибирский онкологический журнал. 2020. 19(4): 7–23
8. World Health Organization Screening for cervical cancer. Published 2020. Available from https://www.who.int/health-topics/cervical-cancer#tab=tab_1 (accessed: 20.10.2022)
9. Atashili J., Smith J.S., Adimora A.A., Eron J., Miller W.C., Myers E. Potential Impact of Antiretroviral Therapy and Screening on Cervical Cancer Mortality in HIV-Positive Women in Sub-Saharan Africa: A Simulation // PLoS One. 2011. 6(4), e18527. 11.
10. Aymon P. Cervical cancer screening: some evidence coming from the north // Cancer J. 1987. 1. P.342.
11. Benard V.B., Thomas C.C., King J., Massetti G.M., Doria-Rose V.P., Saraiya M., et al. Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007–2012 // MMWR Morb Mortal Wkly Rep. 2014. 63(44):1004–9.
12. Cervical cancer screening in Canada: Environmental scan (2018) – Canadian Partnership Against Cancer. Published 2019. https://www.partnershipagainstcancer.ca/topics/cervical-cancer-screening-environmental-scan-2018 (accessed: 20.10.2022)
13. Cheung L.C., Ramadas K., Muwonge R., Katki H.A., Thomas G., Graubard B.I., Basu P., Sankaranarayanan R., Somanathan T., Chaturvedi A.K. Risk-Based Selection of Individuals for Oral Cancer Screening // J Clin.Oncol. 2021. 39(6):663-674.
14. Coleman D.V. The dynamics of the cervical screening programme // Experts’ Conference of 2nd International Congress of Papillomavirus in Human Pathology / Ed. by J. Monsonego-Paris-EUROGIN Sci. Publ. 1994. P.21-25.
15. Committee on Practice B-G. ACOG Practice Bulletin Number 131: Screening for cervical cancer // Obstet Gynecol. 2012. 120(5):1222–38.
16. Esserman L.J., La Croix A.Z. Precision risk-based screening might maximize benefit and minimize harm // Nat RevClin Oncol. 2018. 15(11):661-662. doi: 10.1038/s41571-018-0093-0.
17. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012 // International Journal of Cancer, 2015. 136, E359-E386. https://doi.org/10.1002/ijc.29210. (accessed: 23.10.2022)
18. Gincburg O.M. Fighting breast and cervical cancer in low- and middle-income countries: human rights match sound health policy // Politics J Canc. 2013. 1(3–4): e35e41.
19. Harkness E.F., Astley S.M., Evans D.G. Risk-based breast cancer screening strategies in women // Best Pract Res Clin Obstet Gynaecol. 2020. 65:3-17. doi:10.1016/j.bpobgyn.2019.11.005.
20. Institute of Biomedical Science. The challenges of NHS Cervical Cancer Screening // Available from: https://www.ibms.org/resources/news/the-challenges-of-nhs-cervical-cancer-screening/ 2018 Jan 26. (accessed: 15.10.2022)
21. International Agency for Research on Cancer. Cervical cancer screening. Cancer prevention guide of IARC. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Cervix-Cancer-Screening-2005/ Vol. 10. Lion, Frantsiya: IARC Press; 2005. pр.302. (accessed: 15.10.2022)
22. Kaprin A.D., Novikova E.G., Trushina O.I., Gretzova O.P. The cervical cancer screening – unsolved problems // Research and practical medicine journal. Vol 2, No 1 (2015) https://doi.org/10.17709/2409-2231-2015-2-1-36-41 (accessed: 15.10.2022)
23. Kelias Firi Msyamboza, Twambilire Phiri, Uesli Sihali, Villi Kvenda, Fanni Kachale. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study // BMC Public Health. 2016 17 august; 16 (1): 806. doi: 10.1186 / s12889-016-3530-u.
24. Leinonen M.K., Campbell S., Klungsoyr O., Lönnberg S., Hansen B.T., Nygard M. Personal and provider level factors influence participation to cervical cancer screening: A retrospective register-based study of 1.3 million women in Norway // Prev Med. 2017;94:31-39. doi: 10.1016/j.ypmed.2016.11.018.
25. Li R., Lewkowitz A.K., Zhao F.H., Zhou Q., Hu S.Y., Qiu H., Zhang Y., Jiang H.W., Zhang J.S., Li M., Tong S.M., Zhang Q.Y., Qiao Y.L. Analysis of the effectiveness of visual inspection with acetic acid // Lugol's iodine in one-time and annual follow-up screening in rural China. Arch Gynecol Obstet. 2012. 285(6):1627-32
26. Lucyna Januszek-Michalecka, Ewa Nowak-Markwitz, Paulina Banach, Marek Spaczynski Effectiveness of the National Population-Based Cervical Cancer Screening Programme in Poland--outcomes, problems and possible solutions 7 years after implementation // Ann Agric Environ Med. 2013. 20(4):859-64.
27. Lynge E., Andersen B., Christensen J., Ejersbo D., Jochumsen K., Johansen T., Kristensen J.K., Larsen L.G., Mehnert F., Mikkelsen E., Nielsen K., Rygaard C., Serizawa R., Waldstrom M. Cervical screening in Denmark - a success followed by stagnation // Acta Oncol. 2018. 57(3): 354-361. doi: 10.1080/0284186X.2017.1355110.
28. Marc Arbyn. Prevention of cervical cancer in Europe // Evropeyskiy zhurnal po seksualnomu i reproduktivnomu zdorovyu No.64 – 2007. Available from: https://www.euro.who.int/__data/assets/pdf_file/0008/69767/en64r.pdf (accessed: 22.10.2022)
29. Marlow L.V., Wardle J., Waller J. Understanding cervical screening non-attendance among ethnic minority women in England // BJC. 2015;113: 833–839.
30. Mindaugas Stankūnas, Kersti Pärna et al. Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation? // Acta Med Litu. 2022. 29(1):19-26. doi: 10.15388/Amed.2022.29.1.18.
31. Moss J.L., Liu B., Feuer E.J. Urban/rural differences in breast and cervical cancer incidence: The mediating roles of socioeconomic status and provider density // Women’s Health Issues. 2017. 27(6):683. doi:10.1016/J.WHI.2017.09.008
32. National health insurance found. Screenings for women 2021 Jul 25. Available from: https://www.haigekassa.ee/ru/celoveku/profilaktika-boleznei/obsledovania-po-vyavleniu-raka-dla-zensin (accessed: 22.10.2022)
33. Partanen V.M., Heinävaara S., Pankakoski M., Sarkeala T., Dillner J., Anttila A., Lönnberg S. Nord Screen: Performance and outcome of cancer screening in the Nordic countries (2018). NIASC Nordic Center of Excellence in Health-related eSciences. Karolinska Institutet. 2021 Aug 24. Available from: http://www.nordscreen.org
34. Pashayan N., Morris S., Gilbert F.J., Pharoah P.D.P. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model // JAMA Oncol. 2018. 4(11):1504-1510. doi: 10.1001/jamaon-col.2018.1901. (accessed: 12.10.2022)
35. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials // Lancet. 2014. 383(9916):524–32.
36. Rоzemeijer K., de Kоk Inge M.C.M., Naber S.K., van Kemenade F.J., Penning C. et al. Оffering Self-Sampling tо NоnAttendees оf Оrganized Primary HPV Screening: When Dо Harms Оutweigh the Benefi ts? Cancer Epidemiоl. Biоmarkers Prev. 24, 773–82 (2015). doi:10.1158/1055–9965.EPI-14–0998 Published May 2015
37. Sarkeala T. Finland’s mass cancer screening at 50 – the cervical cancer success story. 2022 Jun 4. Available from: https://www.cancersociety.fi/news/releases/finlands-mass-cancer-screening-50-cervical-cancer-success-story/.(accessed: 20.10.2022)
38. Syuzanna M. Garland, Nirdzha Bhatla i Hekstan I.S. Ngan Cervical Cancer Burden and Prevention Strategies: Asia Oceania Perspective // Cancer Epidemiol Biomarkers Prev. 2012. 21 (9): 1414–1422. doi: 10.1158 /1055-9965.EPI-12-0164.
39. The Nordscreen. Cervical cancer fact sheet. 2017. 2021 Jul 30. Available from: https://nordscreen.org/wp-content/uploads/2017/07/cervix-fact-sheet-estonia-2017.pdf (accessed: 18.10.2022)
40. Uolsh B., Sills M., O’Ne'jl C. The role of private health insurance in socio-economic disparities in cancer screening in Ireland // Economy Health. 2012. 21: 1250–1256.
41. Veerus P., Arbyn M., Amati C., Paolo B. EUROCHIP Working Group. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia // Tumori. 2010. 96(4):524-528.
42. Vesna K., Mario Polyak, Svetlana Rogovskaya. Cervical Cancer Burden and Prevention Activities in Europe // Cancer Epidemiol Biomarkers Prev. 2012. 21 (9): 1423–1433. DOI: 10.1158 / 1055-9965.EPI-12-0181, sentyabr 2012 g.
43. Watson M., Benard V., King J., Crawford A., Saraiya M. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey // Prev Med. 2017. 100:243–7.
44. YuNFPA «Comprehensive programs prevention and reduction incidence of cervical cancer Guidance for States», February 2011. Available from: https://www.unfpa.org/sites/default/files/resource-pdf/RUSSIAN-%20Cervical%20Cancer%20Guidance_0.pdf (accessed: 22.10.2022)
References: [1-7]
1. Bebneva Т.N., Prilepskaya V.N. Профилактика рака шейки матки: скрининг (обзор литературы) [Prevention of cervical cancer: screening (literature review)]. Доктор Ру [Dr. Ru].2009. № 6. pp. 11–17. [in Russian]
2. Bekmuhambetov E.Zh., Balmagambetova S.K. Современные тенденции скрининга рака шейки матки
[Current trends in cervical cancer screening]. Онкология и радиология Казахстана [Oncology and radiology of Kazakhstan]. 2017. № 2(44). pp. 30-33. [in Russian]
3. Bestayeva N.V., Nazarova N.М., Prilepskaya V.N., Тrofimov D.Yu., Burmenskaya О.V., Sulamanidze L.А. Папилломавирусная инфекция: новые взгляды на диагностику и лечение (обзор литературы) [Papillomavirus infection: new views on diagnosis and treatment (literature review)]. Гинекология [Gynecology]. 2013. № 3.pp. 4–6. [in Russian]
4. Данные НИИ онкологии и радиологии [Data from the Research Institute of Oncology and Radiology]. https://onco.kz/skrining-na-rannee-vyyavlenie-raka-molochnoj-zhelezy (accessed: 10.10.2022). [in Russian]
5. Serov V.N, Tverdicova M.A., Tyutyunnik V.L. Папилломавирусная инфекция гениталий: основные принципы лечения [Papillomavirus infection of the genitals: basic principles of treatment]. Русский медицинский журнал [Russian Medical Journal]. 2010. № 18(19). pp. 1170–1173. [in Russian]
6. Shalabekova M.T., Kudajbergenova T.A. Влияние программ популяционного скрининга на показатели рака репродуктивной системы [The Impact of Population Screening Programs on Reproductive System Cancer Rates]. Вестник Алматинского государственного института усовершенствования врачей. [Bulletin of the Almaty State Institute for the Improvement of]. 2018. № 3. pp. 67–75. [in Russian]
7. Shamsutdinova A.G., Turdalieva B.A., Ramazanova B.A., Beltenova A.G. Приверженность к скринингу рака молочной железы и рака шейки матки в Казахстане с позиций соблюдения этических принципов [Adherence to screening for breast and cervical cancer in Kazakhstan from the standpoint of compliance with ethical]. Сибирский онкологический журнал [Siberian journal of oncology]. 2020. 19(4): pp.7–23. [in Russian]
Number of Views: 85
Category of articles:
Reviews
Bibliography link
Zhetpisbayeva I., Каssymbekova F., Sarmuldaeva Sh., Glushkova N. Problems of implementation of screening programs for cervical cancer. The role of adherence of the female population In the efficiency of screening for cervical cancer. Literature review // Nauka i Zdravookhranenie [Science &Healthcare]. 2022, (Vol.24) 6, pp. 212-220. doi 10.34689/SH.2022.24.6.026Related publications:
INTERRELATION OF INTRAABDOMINAL HYPERTENSION AND MARKERS OF GASTROINTESTINAL TRACT INJURY IN PATIENTS WITH MULTIORGAN DYSFUNCTION
DRUG-INDUCED LIVER INJURY AND GENDER DIFFERENCES
QUALITY OF LIFE IN PRIMARY BILIARY CHOLANGITIS AND ITS ASSESSMENT
DIAGNOSTIC AND THERAPEUTIC LAPAROSCOPY FOR ABDOMINAL INJURIES. REVIEW
METHODS FOR SCHOOL-AGE CHILDREN NUTRITIONAL STATUS ASSESSMENT: FOCUS ON ANTHROPOMETRIC PARAMETERS. A REVIEW.